Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY
- PMID: 35554678
- DOI: 10.1007/s00535-022-01877-5
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY
Abstract
Background: This is the first report from a multicenter prospective cohort study of colorectal neuroendocrine tumor (NET), the C-NET STUDY, conducted to assess the long-term outcomes of the enrolled patients. This report aimed to elucidate the clinicopathological features of the enrolled patients and lesions.
Methods: Colorectal NET patients aged 20-74 years were consecutively enrolled and followed up at 50 institutions. The baseline characteristics and clinicopathological findings at enrollment and treatment were assessed.
Results: A total of 495 patients with 500 colorectal NETs were included. The median patient age was 54 years, and 85.3% were asymptomatic. The most frequent lesion location was the lower rectum (88.0%); 99.4% of the lesions were clinically diagnosed to be devoid of metastatic findings, and 95.4% were treated with endoscopic resection. Lesions < 10 mm comprised 87.0% of the total, 96.6% had not invaded the muscularis propria, and 92.6% were classified as WHO NET grade 1. Positive lymphovascular involvement was found in 29.2% of the lesions. Its prevalence was high even in small NETs with immunohistochemical/special staining for pathological assessment (26.4% and 40.9% in lesions sized < 5 mm and 5-9 mm, respectively). Among 70 patients who underwent radical surgery primarily or secondarily, 18 showed positive lymph node metastasis.
Conclusions: The characteristics of real-world colorectal NET patients and lesions are elucidated. The high positivity of lymphovascular involvement in small NETs highlights the necessity of assessing the clinical significance of positive lymphovascular involvement based on long-term outcomes, which will be examined in later stages of the C-NET STUDY.
Trial registration number: UMIN000025215.
Keywords: Colonoscopy; Colorectal neuroendocrine tumors; Endoscopic resection; Lymphovascular involvement.
© 2022. Japanese Society of Gastroenterology.
Similar articles
-
Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.Br J Surg. 2018 Oct;105(11):1480-1486. doi: 10.1002/bjs.10901. Epub 2018 Jun 12. Br J Surg. 2018. PMID: 29893418
-
A nationwide, multi-institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan.Ann Gastroenterol Surg. 2020 Nov 17;5(2):215-220. doi: 10.1002/ags3.12403. eCollection 2021 Mar. Ann Gastroenterol Surg. 2020. PMID: 33860141 Free PMC article.
-
Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.J Gastroenterol. 2015 Dec;50(12):1184-9. doi: 10.1007/s00535-015-1079-7. Epub 2015 May 5. J Gastroenterol. 2015. PMID: 25936647
-
Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.Pathol Res Pract. 2019 Nov;215(11):152642. doi: 10.1016/j.prp.2019.152642. Epub 2019 Sep 21. Pathol Res Pract. 2019. PMID: 31585816
-
Treatment strategy and post-treatment management of colorectal neuroendocrine tumor.DEN Open. 2023 Jun 12;4(1):e254. doi: 10.1002/deo2.254. eCollection 2024 Apr. DEN Open. 2023. PMID: 37313123 Free PMC article. Review.
Cited by
-
Analysis of the Genetic Characteristics and Metastatic Pathways of G1 and G2 Colorectal Neuroendocrine Neoplasms.J Endocr Soc. 2023 Dec 26;8(2):bvad168. doi: 10.1210/jendso/bvad168. eCollection 2024 Jan 5. J Endocr Soc. 2023. PMID: 38205165 Free PMC article.
-
Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis.Int J Endocrinol. 2022 Dec 19;2022:1720624. doi: 10.1155/2022/1720624. eCollection 2022. Int J Endocrinol. 2022. PMID: 36578535 Free PMC article.
-
Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors.Int J Colorectal Dis. 2023 Feb 13;38(1):37. doi: 10.1007/s00384-023-04331-x. Int J Colorectal Dis. 2023. PMID: 36781493
-
Risk factors for and prognostic impact of lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a single-center retrospective analysis of 214 cases with radical resection.Surg Today. 2025 Feb;55(2):144-153. doi: 10.1007/s00595-024-02905-y. Epub 2024 Aug 28. Surg Today. 2025. PMID: 39196341
-
Current advances in neuroendocrine neoplasms of the colon and rectum.World J Clin Oncol. 2025 Aug 24;16(8):108906. doi: 10.5306/wjco.v16.i8.108906. World J Clin Oncol. 2025. PMID: 40901326 Free PMC article. Review.
References
-
- Who Classification of Tumours Editorial Board (eds). WHO classification of tumours of the digestive system, 5th edn. 2019; Lyon: IARC Press.
-
- Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020;12:791–807. - DOI
-
- Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–42. - DOI
-
- Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58–64. - DOI
-
- Masui T, Ito T, Komoto I, Uemoto S, JNETS Project Study Group. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer. 2020;20:1104. - DOI
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical